State Board of Administration of Florida Retirement System’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,933	Closed	-$54K	–	2450
2022 Q1	$54K	Hold	1,933	–	–	﹤0.01%	2325
2021 Q4	$88K	Hold	1,933	–	–	﹤0.01%	2334
2021 Q3	$161K	Buy	+1,933	New	+$160K	﹤0.01%	2302

Other funds holding ONCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QPW

Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return

State Board of Administration of Florida Retirement System's ONCT Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2022, closing a stake of 1,933 shares — an estimated $54K sold.

State Board of Administration of Florida Retirement System first reported a position in ONCT in Q3 2021 and held it in 3 quarters. The position peaked at $161K in Q3 2021. 75 funds tracked by Wall St. Rank hold ONCT as of Q2 2022.

State Board of Administration of Florida Retirement System reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 1,933 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $54K.
State Board of Administration of Florida Retirement System first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
State Board of Administration of Florida Retirement System's Oncternal Therapeutics, Inc. Common Stock position peaked at $161K in Q3 2021.
75 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.